COMPANION MEETINGS Pulmonary Pathology Society   Saturday, March 17, 2012 — 7:00 p.m. — Convention Centre 301-305  Pulmonary Pathology Practice Guidelines   Moderators: Andrew Churg, University of British Columbia, Vancouver, BC, Canada; Lucian Chirieac, Brigham & Women's Hospital, Boston, MA and Keith Kerr, Aberdeen University School of Medicine, Aberdeen, Scotland Click the button above to add this event to your Itinerary Planner... 7:00 CAP/IASLC/AMP Guidelines for Lung Carcinoma Molecular Testing - Phillip Cagle, The Methodist Hospital, Houston, TX 7:45 Discussion, Question and Answer 8:00 ATS/ERS/JRS/ALAT Guidelines for Diagnosis and Management of Idiopathic Pulmonary Fibrosis - Thomas Colby, Mayo Clinic Scottsdale, Scottsdale, AZ 8:45 Discussion, Question and Answer 9:00 The International Mesothelioma Interest Group Guidelines for Pathologic Diagnosis of Malignant Mesothelioma - Aliya N. Husain, University of Chicago, Chicago, IL 9:45 Discussion, Question and Answer The Pulmonary Pathology Society recognizes significant changes are occurring regarding molecular testing of lung cancer, diagnosis and management of idiopathic pulmonary fibrosis and malignant mesothelioma. This symposium covers the first international comprehensive recommendation for molecular testing in lung carcinomas that represents a new standard in lung cancer diagnosis. A large spectrum of questions related to molecular testing will be addressed including tissue processing, methodology, results interpretation and standardized reporting. The symposium also covers the current state of knowledge regarding diagnosis and treatment of idiopathic pulmonary fibrosis. An update regarding histologic and molecular approach to diagnosis of malignant mesothelioma will be discussed.